Description of Medical ServiceImmunohistochemistry (IHC) testing for identification of mismatch repair deficiency for eligibility to access dostarlimab on the PBS in patients with recurrent or advanced endometrial cancer.
Description of Medical ConditionPatients with recurrent or advanced endometrial cancer which are mismatch repair deficient, who have progressed following prior treatment.
Reason for ApplicationNew MBS item
Medical Service TypeCo-dependent technology
Previous Application Number/sNot Applicable
Application FormApplication Form (PDF 1360 KB)
Application Form (Word 298 KB)
Consultation SurveyConsultation Survey (PDF 584 KB)
Consultation Survey (Word 68 KB)
PASC consultation closed.
MSAC consultation TBA – please subscribe to the MSAC Email Bulletin to be notified when consultation opens for this application.
For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process
PICO ConfirmationPICO Confirmation (PDF 1186 KB)
PICO Confirmation (Word 3820 KB)